| Identification | |
| Name: | Dibenzo[b,f][1,4]thiazepine,11-(1-piperazinyl)- |
| Synonyms: | 11-(1-Piperazinyl)dibenzo[b,f][1,4]thiazepine;11-Piperazinodibenzo[b,f][1,4]thiazepine; N-Desalkylquetiapine |
| CAS: | 5747-48-8 |
| Molecular Formula: | C17H17 N3 S |
| Molecular Weight: | 0 |
| InChI: | InChI=1/C15H10ClNO2/c1-9-4-2-3-5-11(9)14-17-13-8-10(16)6-7-12(13)15(18)19-14/h2-8H,1H3 |
| Molecular Structure: | ![(C17H17N3S) 11-(1-Piperazinyl)dibenzo[b,f][1,4]thiazepine;11-Piperazinodibenzo[b,f][1,4]thiazepine; N-Desalkylqu...](https://img1.guidechem.com/chem/e/dict/104/5747-48-8.jpg) |
| Properties | |
| Flash Point: | 199.2°C |
| Boiling Point: | 405.7°C at 760 mmHg |
| Density: | 1.32g/cm3 |
| Refractive index: | 1.636 |
| Appearance: | Pale-Yellow Solid |
| Specification: | Pale-Yellow Solid usageEng:A metabolite of Quetiapine, a Benzothiazepine with mixed serotonin and dopamine receptor antagonistic properties used as an antipsychotic |
| Flash Point: | 199.2°C |
| Usage: | A metabolite of Quetiapine, a Benzothiazepine with mixed serotonin and dopamine receptor antagonistic properties used as an antipsychotic |
| Safety Data | |
 |
|
